CRCA vs. NOBL
CRCA (ProShares Ultra CRCL) and NOBL (ProShares S&P 500 Dividend Aristocrats ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while NOBL is a Dividend fund tracking the S&P 500 Dividend Aristocrats Index. CRCA is actively managed, while NOBL is passively managed. Their 0.02 correlation means their historical movements had little consistent relationship. CRCA charges 0.95%/yr vs 0.35%/yr for NOBL.
Performance
CRCA vs. NOBL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -70.23% return, which is significantly lower than NOBL's 10.84% return.
CRCA
- 1D
- -5.20%
- 1M
- -12.09%
- 6M
- -51.11%
- YTD
- -70.23%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
NOBL
- 1D
- -0.19%
- 1M
- -1.09%
- 6M
- 4.89%
- YTD
- 10.84%
- 1Y
- 15.41%
- 3Y*
- 8.04%
- 5Y*
- 6.49%
- 10Y*
- 9.86%
- ALL TIME*
- 10.70%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $13.28M | $18.49M | $44.45M | |
| $66.40M | $66.46M | $60.79M |
CRCA vs. NOBL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -70.23% | -84.67% |
NOBL ProShares S&P 500 Dividend Aristocrats ETF | 10.84% | 2.53% |
Correlation
The correlation between CRCA and NOBL is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.02 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. NOBL — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
NOBL
CRCA vs. NOBL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and ProShares S&P 500 Dividend Aristocrats ETF (NOBL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | NOBL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.21 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 1.62 | — |
| Martin ratioReturn relative to average drawdown | — | 4.10 | — |
Loading charts...
Drawdowns
CRCA vs. NOBL - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.61%, which is greater than NOBL's maximum drawdown of -35.43%. Use the drawdown chart below to compare losses from any high point for CRCA and NOBL.
Loading charts...
Drawdown Indicators
| CRCA | NOBL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.61% | -35.43% | -60.18% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.11% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -15.36% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.92% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.43% | — |
Current DrawdownCurrent decline from peak | -95.44% | -2.31% | -93.13% |
Average DrawdownAverage peak-to-trough decline | -74.24% | -3.46% | -70.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.59% | — |
Volatility
CRCA vs. NOBL - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | NOBL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.07% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 9.11% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 193.78% | 11.92% | +181.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 193.78% | 14.48% | +179.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 193.78% | 16.63% | +177.15% |
CRCA vs. NOBL - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than NOBL's 0.35% expense ratio.
Dividends
CRCA vs. NOBL - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 7.40%, more than NOBL's 2.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 7.40% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NOBL ProShares S&P 500 Dividend Aristocrats ETF | 2.04% | 2.14% | 2.05% | 2.09% | 1.94% | 1.89% | 2.14% | 1.89% | 2.37% | 1.74% | 2.13% | 2.02% |
Frequently Asked Questions
CRCA and NOBL have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, NOBL is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
NOBL is cheaper with a 0.35% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 7.40%, compared with 2.04% for NOBL.
CRCA is categorized as Leveraged Equities, while NOBL is Dividend. Their fees differ too: 0.95% for CRCA and 0.35% for NOBL.
Find the right allocation for CRCA and NOBL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer